02559nas 2200601-a 450 991014048220332120240226124422.02041-600810.4155/tde.10.16(OCoLC)669147111(CKB)2900000000000313(CONSER)--2010243759(NjHacI)992900000000000313(EXLCZ)99290000000000031320100823a20109999 --- -engur|||||||||||txtrdacontentnrdamediacrrdacarrierTherapeutic deliveryLondon Future ScienceLondon :Future Science,2010.1 online resource illustrations (some colour)Refereed/Peer-reviewed2041-5990 Transdermal drug delivery is an exciting and challenging area. There are numerous transdermal delivery systems currently available on the market. However, the transdermal market still remains limited to a narrow range of drugs. Further advances in transdermal delivery depend on the ability to overcome the challenges faced regarding the permeation and skin irritation of the drug molecules. Emergence of novel techniques for skin permeation enhancement and development of methods to lessen skin irritation would widen the transdermal market for hydrophilic compounds, macromolecules and conventional drugs for new therapeutic indications. As evident from the ongoing clinical trials of a wide variety of drugs for various clinical conditions, there is a great future for transdermal delivery of drugs.THER DELIVTher DelivTherapeuticsfast(OCoLC)fst01149694TherapeuticsPeriodicalsDrug delivery systemsPeriodicalsTechnology, PharmaceuticalDrug Administration RoutesDrug Delivery SystemsDrug delivery systemsfast(OCoLC)fst00898667Periodical.Periodicals.fastTherapeutics.TherapeuticsDrug delivery systemsTechnology, Pharmaceutical.Drug Administration Routes.Drug Delivery Systems.Drug delivery systems.615.6Paudel Kalpana S.1592771NjHacINjHaclJOURNAL9910140482203321Therapeutic delivery3911953UNINA